GlaxoSmithKline LLC recalls Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 497
Recalled June 1, 2022 · FDA recall D-0896-2022 · GlaxoSmithKline
Hazard
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026. · FDA Class III
Units
328 bottles
Sold at
Nationwide in the U.S.
Description
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.
Product
Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 49702-228-13.
Manufacturer(s)
GlaxoSmithKline LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →